Dow Up 1.01% Nasdaq Up 1.33%

More On NVLX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Nuvilex, Inc. (NVLX)

-Other OTC
0.22 Down 0.01(2.40%) 1:05PM EDT
Prev Close:0.23
Open:0.22
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.22 - 0.23
52wk Range:0.10 - 0.62
Volume:1,171,706
Avg Vol (3m):1,704,690
Market Cap:158.69M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVLX

Comparison

Symbol% ChgMkt Cap
NVLXDown 2.40%158.69M
ECLUp 1.73%33.07B
NATR 0.00%242.87M
PCGR 0.00%47.87K

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvilex, Inc., a biotechnology company, develops treatments for pancreatic cancer, breast cancer, brain cancer, and diabetes through cellulose-based live cell encapsulation technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback